HBeAg negative patients with chronic hepatitis B are less likely to have a biochemical breakthrough during lamivudine treatment
Conference paper > Summary Text · 2005
Authors: Ulus Salih AKARCA, F Gunsar, G Ersoz, T Ozacar, Memnune Selda ERENSOY, M Akyildiz, E Kasap, S Akay, Fatih TEKİN, Abdullah Zeki KARASU, Y Batur, T Ilter
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, France, International, Verbal, Summary Text, 2005-2005, WoS, vol 42, pp 170-170